Results 1 to 10 of about 60 (56)

Inmunoterapia alérgeno específica: Prevalencia de alérgenos en consulta privada de alergología en Cáceres

Archives of Nursing Research, 2018
Según la Sociedad Española de Alergología e Inmunología Clínica (SEAIC), las enfermedades alérgicas afectan a un 30% de la población española. La alergia ocupa la sexta posición dentro de las diez enfermedades o problemas de salud que la población de 15
Olga Leal-Hernández, Mercedes Caballero-Barrantes   +1 more
doaj   +9 more sources

Eficacia y seguridad de la inmunoterapia subcutánea para alérgenos inhalables en pacientes con alergia respiratoria a un año de tratamiento

Revista Alergia México, 2021
Antecedentes: La inmunoterapia específica con alérgenos es una importante modalidad terapéutica para el manejo de la rinitis y asma alérgica. Objetivo: Evaluar la eficacia y seguridad de la inmunoterapia subcutánea con alérgenos en pacientes con ...
Johav Yael Sánchez-Villalobos, Chrystopherson Caballero-López, Aída Inés López-García, Daniela Rivero-Yeverino, Oswaldo Arana-Muñoz, José Sergio Papaqui-Tapia, Juan Jesús Ríos-López, Jonathan Higgins Payán-Diaz, Carlos David López-Romero, Erika Villada-Villada   +9 more
doaj   +1 more source

ALERGENOS AMBIENTALES Y ASMA

Neumología Pediátrica, 2023
La exposición a alergenos inhalantes se asocia con sensibilización alergeno especifica, factor de riesgo para el desarrollo de asma bronquial, junto con factores genéticos y del medio ambiente.
María Angélica Marinovic
doaj   +1 more source

Efecto de la inmunoterapia con alérgenos específicos en pacientes pediátricos con asma atendidos en una institución de salud de Colombia

Biomédica: revista del Instituto Nacional de Salud, 2021
Introducción. El asma es una enfermedad crónica y potencialmente grave. El 80 % de los casos es de origen alérgico, por lo cual la inmunoterapia específica con alérgenos es una alternativa terapéutica que modula el curso natural de la enfermedad ...
Jorge Andrés Puerto, Susana Uribe, Víctor Calvo, Ricardo Cardona   +3 more
doaj   +1 more source

The safety of rush immunotherapy in the management of canine atopic dermatitis—230 cases

Veterinary Dermatology, Volume 34, Issue 5, Page 385-392, October 2023., 2023
Background – The duration of the induction phase of allergen‐specific immunotherapy conventionally is a period of several weeks, during which the volume of an allergen solution, administered by injection, is gradually increased until the maintenance dose is reached.
Tamara Weitzer, Ralf Mueller
wiley   +1 more source

Equine allergic skin diseases: Clinical consensus guidelines of the World Association for Veterinary Dermatology

Veterinary Dermatology, Volume 34, Issue 3, Page 175-208, June 2023., 2023
Abstract Background Allergic skin diseases are common in horses worldwide. The most common causes are insect bites and environmental allergens. Objectives To review the current literature and provide consensus on pathogenesis, diagnosis, treatment and prevention. Materials and Methods The authors reviewed the literature up to November 2022.
R. Marsella, S. White, V. A. Fadok, D. Wilson, R. Mueller, C. Outerbridge, W. Rosenkrantz   +6 more
wiley   +1 more source

A randomised, double‐blinded comparison between subcutaneous rush and intralympathic allergen immunotherapy induction in atopic dogs

Veterinary Dermatology, Volume 34, Issue 2, Page 91-98, April 2023., 2023
Background – Atopic dermatitis (AD) is one of the most common skin diseases in small animal practice. Allergen immunotherapy (AIT) is the only curative treatment for the disease, and oral, subcutaneous and intralymphatic administration of allergens are commonly employed.
Ralf S. Mueller, Yuri Zablotski, Katja Baumann, Teresa Boehm, Bettina Kasper, Christoph Klinger, Maarten Monke, Laura Udraite‐Vovk, Tamara Weitzer, Natalie K. Y. Gedon   +9 more
wiley   +1 more source

Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases

Veterinary Dermatology, Volume 33, Issue 4, Page 321-e75, August 2022., 2022
Background –Canine atopic dermatitis (cAD) is an allergic skin disease affecting approximately 10% of dogs. Allergen immunotherapy (AIT) is currently the only treatment option able to induce tolerance to the causative allergens. Objective – To retrospectively establish the efficacy of AIT in atopic dogs.
Evelien E. M. Fennis, Catharina M. M. van Damme, Yvette M. Schlotter, Jacqueline D. Sinke, Mieke H. G. Leistra, Richard T. Bartels, Femke Broere   +6 more
wiley   +1 more source

Immunopathogenesis and immunotherapy of Culicoides hypersensitivity in horses: an update

Veterinary Dermatology, Volume 32, Issue 6, Page 579-e156, December 2021., 2021
Culicoides hypersensitivity (CH) is a strongly pruritic dermatitis of horses, characterised histologically by mixed perivascular to diffuse cellular infiltrates of mononuclear cells and eosinophils, and caused by helper T cell (Th)2, immunoglobulin (Ig)E‐mediated reactions to antigens present in the saliva of biting Culicoides midges.
Eliane Marti, Ella N. Novotny, Iva Cvitas, Anja Ziegler, A. Douglas Wilson, Sigurbjörg Torsteinsdottir, Antonia Fettelschoss‐Gabriel, Sigridur Jonsdottir   +7 more
wiley   +1 more source

Reproducibility of serum testing for environmental allergen‐specific IgE in dogs in Europe

Veterinary Dermatology, Volume 32, Issue 3, Page 251-e67, June 2021., 2021
Background – Serum testing for allergen‐specific immunoglobulin (Ig)E is commonly employed to identify allergens used for allergen‐specific immunotherapy in dogs, yet the reliability of results has been a matter of debate. Objective – The aim of this study was to evaluate the reproducibility of serum tests for environmental allergen‐specific IgE in ...
Katja N. Baumann, Natalie K.Y. Gedon, Teresa M.S.A. Boehm, Laura Udraite‐Vovk, Ralf S. Mueller   +4 more
wiley   +1 more source